Have you been recently diagnosed with T1D? You may be able to participate in a research study for an investigational cell therapy product to see if it is safe for patients with T1D and to see if it helps to slow down the progression of T1D.

The purpose of this study is to evaluate the distribution of a human leukocyte antigen genotype in adults who were recently diagnosed with type 1 diabetes

The purpose of this study is to determine if an investigational treatment can address the underlying cause of Graves' disease, and potentially normalize thyroid hormone levels.

This study is being done to see if an investigational medication works better than a placebo (dummy medicine) for weight loss.

Many patients with type 2 diabetes do not achieve their goals for managing their blood sugar and are therefore at risk for developing complications, despite treatment with insulin and other medications for diabetes. Automated insulin delivery systems have been shown to be beneficial for patients with type 1 diabetes, and may be equally beneficial for patients with type 2 diabetes.

The purpose of this study is to determine the efficacy and safety of an investigational oral medication compared with placebo in people with obesity or overweight with and without type 2 diabetes

Do you have type 1 diabetes? Has your doctor told you that your HbA1c is higher than the goal? Do you also have excess body weight? If you are having a hard time controlling your blood sugar with only insulin, you may be able to participate in a research study to see if taking an investigational medication once weekly can help improve your blood sugar control and reduce your body weight.

Do you have high blood pressure even though you are taking 3 or 4 different medications to treat it? You might be able to participate in a study to find out if you also have high cortisol levels.

What factors influence how the brain takes in sugar to use it as energy? If you are between the ages of 18-45 years old and are healthy and of normal weight, you might be eligible to participate in this study to help us understand how the way sugar enters the body affects how sugar enters the brain.

The purpose of this study is to find out whether the addition of HDV to Humalog® will improve diabetes control by reducing high blood sugar after meals and/or reducing the risk of low blood sugar (hypoglycemia) during insulin treatment. The safety and tolerability of Humalog® with or without added HDV will also be evaluated. The study drugs will be administered by subcutaneous (under the skin) injection.